Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed
A Texas federal judge has denied Strive Specialties Inc.'s bid to undo her judgment dismissing the compounding pharmacy's lawsuit that accuses Eli Lilly and Novo Nordisk of blocking competition for GLP-1...To view the full article, register now.
Already a subscriber? Click here to view full article